The National Institutes of Health (NIH) is offering this grant to support innovative, multidisciplinary research aimed at developing and testing interventions. This grant is for the purpose of optimizing comprehensive care for individuals with Type 2 Diabetes Mellitus from health disparity populations. These populations include racial and ethnic minorities, sexual and gender minorities, socioeconomically disadvantaged groups, and underserved rural communities. Proposed projects should focus on patient-centered strategies that align with evidence-based guidelines, ensuring optimal glycemic control alongside other critical recommendations. This includes promoting annual eye/foot and urine albumin exams, achieving optimal blood pressure control, and ensuring appropriate intake of prescribed medications (ACEIs/ARBs/statins/aspirin) and relevant vaccinations (influenza/pneumonia). The goal is to improve health outcomes and reduce disparities in diabetes management.
Opportunity ID: 333817
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PA-21-232 |
| Funding Opportunity Title: | Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Food and Nutrition Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.307 — Minority Health and Health Disparities Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | May 26, 2021 |
| Last Updated Date: | May 26, 2021 |
| Original Closing Date for Applications: | Sep 07, 2024 |
| Current Closing Date for Applications: | Sep 07, 2024 |
| Archive Date: | Oct 13, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $500,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses County governments Special district governments Independent school districts Public and State controlled institutions of higher education Private institutions of higher education Native American tribal governments (Federally recognized) Others (see text field entitled “Additional Information on Eligibility” for clarification) State governments Small businesses City or township governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to support innovative multidisciplinary and multi-level research designed to develop and/or test interventions to optimize care of persons with Type 2 diabetes from populations with health/health care disparities concordant with evidence-based guidelines. NIH-designated health disparity populations include racial and ethnic minorities (Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asians, Native Hawaiians and other Pacific Islanders), sexual and gender minorities, socioeconomically disadvantaged populations, and underserved rural populations. Proposed projects would be expected to develop and/or test patient-centered strategies, which in addition to optimal glycemic control, would aim at completing other recommended guidelines (e.g., annual eye/foot and urine albumin exam, optimal blood pressure control, intake of ACEIs or ARBs/statin/aspirin and influenza/pneumonia vaccines). |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PA-21-232.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 333817 Full Announcement-PA-21-232 -> PA-21-232-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH OER Webmaster grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-G | Use for due dates on or before January 24, 2023 | PKG00269690 | Oct 28, 2021 | Jan 24, 2023 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00267362 | Sep 06, 2021 | Jan 24, 2022 | View | |
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00277684 | Nov 01, 2022 | Sep 07, 2024 | View |
Package 1
Mandatory forms
333817 RR_SF424_5_0-5.0.pdf
333817 PHS398_CoverPageSupplement_5_0-5.0.pdf
333817 RR_OtherProjectInfo_1_4-1.4.pdf
333817 PerformanceSite_4_0-4.0.pdf
333817 RR_KeyPersonExpanded_4_0-4.0.pdf
333817 PHS398_ResearchPlan_4_0-4.0.pdf
333817 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
333817 RR_Budget_3_0-3.0.pdf
333817 RR_SubawardBudget30_3_0-3.0.pdf
333817 PHS398_ModularBudget_1_2-1.2.pdf
333817 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 2
Mandatory forms
333817 RR_SF424_2_0-2.0.pdf
333817 PHS398_CoverPageSupplement_5_0-5.0.pdf
333817 RR_OtherProjectInfo_1_4-1.4.pdf
333817 PerformanceSite_2_0-2.0.pdf
333817 RR_KeyPersonExpanded_2_0-2.0.pdf
333817 PHS398_ResearchPlan_4_0-4.0.pdf
333817 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
333817 RR_Budget_1_4-1.4.pdf
333817 RR_SubawardBudget30_1_4-1.4.pdf
333817 PHS398_ModularBudget_1_2-1.2.pdf
333817 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
333817 RR_SF424_5_0-5.0.pdf
333817 PHS398_CoverPageSupplement_5_0-5.0.pdf
333817 RR_OtherProjectInfo_1_4-1.4.pdf
333817 PerformanceSite_4_0-4.0.pdf
333817 RR_KeyPersonExpanded_4_0-4.0.pdf
333817 PHS398_ResearchPlan_5_0-5.0.pdf
333817 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
333817 RR_Budget_3_0-3.0.pdf
333817 RR_SubawardBudget30_3_0-3.0.pdf
333817 PHS398_ModularBudget_1_2-1.2.pdf
333817 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
